CVM:CEL-SCI Corp Snapshot | Charting | News | Options
$1.27 NYSE MKT LLC 9:00a ET
May 16 '24 		CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results BusinessWire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on CVM
    No News Available
    CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine...
    9:00a ET May 8 '24 BusinessWire
    CEL-SCI Appoints Mario Gobbo to Its Board of Directors
    9:00a ET April 23 '24 BusinessWire
    CEL-SCI's LEAPS Vaccine Offers Promising New Paradigm to Treat Rheuma...
    9:00a ET March 19 '24 BusinessWire
    CEL-SCI Corporation Issues Letter to Shareholders
    8:45a ET March 6 '24 BusinessWire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.